Invivyd Inc.
Organization details
- Legal name
- Invivyd Inc.
- Former names
- Adagio Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New Haven
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IVVD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001832038
- EIN
- 85-1403134
Board of directors
-
Ajay Royan · DirectorSince 2025
-
Christine Lindenboom · DirectorSince 2023
-
Clive Meanwell · DirectorSince 2023
-
David Hering · Director · Chief Executive OfficerSince 2023
-
Ian Sheffield · DirectorSince 2026
-
Kevin F. Mclaughlin · DirectorSince 2024
-
Marc Elia · Director · Chief Executive OfficerSince 2023
-
Michael S. Wyzga · DirectorSince 2023
-
Paul Bolno · DirectorSince 2025
-
Sara Cotter · DirectorSince 2023
-
Srishti Gupta · DirectorSince 2024
-
Tamsin Berry · DirectorSince 2023
- Since 2023
-
Tomas J. Heyman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.0%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
-
99.9%
Board connections
10 of this board's directors also sit on 14 other boards. 13 are in the same sector.
-
Fractyl Health Inc. Same sectorvia Ajay Royan, Clive Meanwell, Ian Sheffield and Marc Elia
-
Alector Inc. Same sectorvia Terrance Mcguire
-
Exelixis Inc. Same sectorvia Tomas J. Heyman
-
Korsana Biosciences Inc. Same sectorvia Terrance Mcguire
-
Legend Biotech Corporation Same sectorvia Tomas J. Heyman
-
Mereo BioPharma Group plc Same sectorvia Michael S. Wyzga
-
NovaBridge Biosciences Same sectorvia Srishti Gupta
- via Terrance Mcguire
-
Tectonic Therapeutic Inc. Same sectorvia Terrance Mcguire
-
Tvardi Therapeutics Inc. Same sectorvia Michael S. Wyzga
-
Vericel Corporation Same sectorvia Kevin F. Mclaughlin
-
Wave Life Sciences Inc. Same sectorvia Paul Bolno
-
X4 Pharmaceuticals Inc. Same sectorvia Michael S. Wyzga
-
Xilio Therapeutics Inc. Same sectorvia Tomas J. Heyman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $125,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $531,074
- 20 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Allen Robert D. III Officer (Chief Scientific Officer) | Open-market sale | −17,043 | $0.84 | $14,316 |
| Aug 18, 2026 | Andersen Jill Officer (Chief Legal Officer, Secretary) | Open-market sale | −30,706 | $0.84 | $25,793 |
| Aug 18, 2026 | Duke William E. Officer (Chief Financial Officer) | Open-market sale | −18,425 | $0.84 | $15,477 |
| Aug 18, 2026 | Green Julie Officer (Chief Human Resources Officer) | Open-market sale | −18,425 | $0.84 | $15,477 |
| Aug 18, 2026 | Lee Timothy Edward Officer (Chief Commercial Officer) | Open-market sale | −18,425 | $0.84 | $15,477 |
| Aug 17, 2026 | Allen Robert D. III Officer (Chief Scientific Officer) | Open-market sale | −20,679 | $0.72 | $14,889 |
| Aug 17, 2026 | Andersen Jill Officer (Chief Legal Officer, Secretary) | Open-market sale | −37,256 | $0.72 | $26,824 |
| Aug 17, 2026 | Duke William E. Officer (Chief Financial Officer) | Open-market sale | −22,355 | $0.72 | $16,096 |
| Aug 17, 2026 | Green Julie Officer (Chief Human Resources Officer) | Open-market sale | −22,355 | $0.72 | $16,096 |
| Aug 17, 2026 | Lee Timothy Edward Officer (Chief Commercial Officer) | Open-market sale | −22,355 | $0.72 | $16,096 |
| Aug 15, 2026 | Allen Robert D. III Officer (Chief Scientific Officer) | Option exercise | +102,000 | — | — |
| Aug 15, 2026 | Andersen Jill Officer (Chief Legal Officer, Secretary) | Option exercise | +170,000 | — | — |
| Aug 15, 2026 | Duke William E. Officer (Chief Financial Officer) | Option exercise | +102,000 | — | — |
| Aug 15, 2026 | Green Julie Officer (Chief Human Resources Officer) | Option exercise | +102,000 | — | — |
| Aug 15, 2026 | Lee Timothy Edward Officer (Chief Commercial Officer) | Option exercise | +102,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Invivyd Inc.
Who is the CEO of Invivyd Inc.?
David Hering is Invivyd Inc.'s Chief Executive Officer.
How many directors are on Invivyd Inc.'s board?
Invivyd Inc.'s board has 14 directors: Ajay Royan, Christine Lindenboom, Clive Meanwell, David Hering, Ian Sheffield, Kevin F. Mclaughlin, Marc Elia, Michael S. Wyzga, Paul Bolno, Sara Cotter and 4 others.
Are Invivyd Inc. insiders buying or selling shares?
Over the last 12 months, Invivyd Inc. insiders bought $125,000 of shares in 1 purchase and sold $531,074 of shares in 20 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="invivyd-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.